Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $580,406 - $685,154
-5,800 Reduced 29.74%
13,700 $48.5 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $1.96 Million - $2.19 Million
19,500 New
19,500 $115 Million
Q3 2023

Nov 09, 2023

BUY
$95.53 - $114.62 $1.93 Million - $2.32 Million
20,200 New
20,200 $1.96 Million
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $1.41 Million - $1.66 Million
-14,600 Reduced 56.15%
11,400 $4,000
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $579,866 - $680,272
6,100 Added 30.65%
26,000 $52,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $154,816 - $179,248
1,600 Added 8.74%
19,900 $331,000
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $224,553 - $271,414
-2,200 Reduced 10.73%
18,300 $251,000
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $524,492 - $639,584
-4,600 Reduced 18.33%
20,500 $135,000
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $196,401 - $240,482
1,700 Added 7.26%
25,100 $35,000
Q3 2021

Nov 10, 2021

SELL
$116.66 - $129.06 $69,996 - $77,436
-600 Reduced 2.5%
23,400 $106,000
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $1.06 Million - $1.25 Million
10,000 Added 71.43%
24,000 $109,000
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $1.1 Million - $1.3 Million
-10,100 Reduced 41.91%
14,000 $78,000
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $640,500 - $697,962
-6,100 Reduced 20.2%
24,100 $61,000
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $137,460 - $166,935
1,500 Added 5.23%
30,200 $94,000
Q2 2020

Aug 10, 2020

BUY
$76.57 - $98.0 $375,192 - $480,200
4,900 Added 20.59%
28,700 $95,000
Q1 2020

May 08, 2020

BUY
$62.82 - $91.86 $854,352 - $1.25 Million
13,600 Added 133.33%
23,800 $192,000
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $800,802 - $891,480
10,200 New
10,200 $19,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.